Rare and genetically driven diseases often lack timely diagnosis and therapies matched to the underlying molecular cause.
R&D Focus
AlphaRose Therapeutics develops precision medicine for genetic diseases, focusing on autism and neuro-genetic disorders
Innovative Solution
Chrysalis Genetics focuses on developing programmable precision medicine aimed at treating genetic diseases.
Investment Funding
Revenue
$1M to $10M
People
Founders
Casey McPherson
About
Chrysalis Genetics focuses on developing programmable precision medicine aimed at treating genetic diseases. The company is dedicated to creating treatments for children with autism, special needs, and other neuro-genetic disorders.
Products
Demo Product or Complete Product?
Development stage
Something missing or incorrect on this page? Help us enrich this information
